Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

NDI Notifications For CBD ‘Excluded’ On Arrival But US FDA Still Explains Where Safety Evidence Fails

Aug 11 2021

• By Malcolm Spicer

Related Content

Future Of CBD In Supplements: NDI Notification Looms As Regulatory Path

Dec 03 2019

Schumer Includes Cannabinoid Pathway For Supplements In Cannabis Legalization Draft Bill

Jul 14 2021

Mixing Food In Legislation Changing US FDA Cannabinoid Rules Could Choke Its Progress

May 25 2021

Additional Topics

International United States Cannabidiol CBD FDA Ingredients Advertising, Marketing & Sales Business Strategies Commercial Companies Dietary Supplements Enforcement Politics Policy Regulation Legislation Consumer

More from Cannabis/CBD

More from Ingredients & Safety

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window